Case Report of Skin Lesions in COVID-19 Patients in a Private Hospital, Thailand in April 2020.

Main Article Content

นาธาน กุลภัทรเวท

Abstract

This report examined rash in COVID-19 patients by demonstrating a real case.
The participant was a 28-year-old Thai female, who had no food or drug allergies.
After having a fever for two days, she was detected with a COVID-19 infection together
with muscular pain, rash on the extremities, and watery diarrhea for three times.
Physical examination: There were multiple discrete blanchable erythematous
macules and papules on the upper and lower extremities (both arms and thighs),
no involvement in other parts of the skin area; such as, the conjunctiva, face, oral area,
trunk, genitals, palms, and soles.
Impression: Skin appearance of Coronavirus.
Differential diagnosis: Chikungunya, Zika, measles, rubella, infectious mononucleosis,
dengue fever and dengue hemorrhagic fever, acute retroviral syndrome, secondary syphilis,
Scrub typhus, lepromatous leprosy and Candidiasis.
Laboratory investigation: A complete blood count (CBC) showed no surging
eosinophil, which inferred that there was no internal organ damage from any medication.
A biopsy was not recommended because this would not help to indicate the viral
infection apart from suspecting a severe drug allergy. The liver function and urine analysis
were also normal in this case.
Treatment: Topical corticosteroid; oral antihistamine. In this case, topical
corticosteroid was applied two times per day then the rash faded within two days
without postinflammatory hyperpigmentation.
Conclusion: As COVID-19 is a new emerging disease, the information about skin
lesions in this viral infection is still limited. Furthermore, many articles have reported
different types of skin rash as part of COVID-19, including maculopapular rash (MP rash),
vesicular, urticarial lesion, liveo reticularis, violaceous rash, COVID toe, petechiae and
purpura, and papulosquamous lesions. MP rash is the most common skin lesion from
COVID-19; conversely, the rash was not the indicator for the severity of the infection.
Hence, further study would still be needed.

Article Details

How to Cite
1.
กุลภัทรเวท น. Case Report of Skin Lesions in COVID-19 Patients in a Private Hospital, Thailand in April 2020. IUDCJ [Internet]. 2021 Aug. 30 [cited 2024 Apr. 26];6(1):13-22. Available from: https://he01.tci-thaijo.org/index.php/iudcJ/article/view/247298
Section
Academic Articles

References

1.Amanda Oakley Exanthems.Derm Net NZ.updated 2015[cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/exanthems/
2.ลีนา จุฬาโรจน์มนตรี,นฤมล ศิลปอาชา,ชุดา รุจิธารณวงศ์,บรรณาธิการ.Sirirag’s Derm Diaries Book2.กรุงเทพมหานคร: เรือนแก้วการพิมพ์; 2563.
3. Tay MZ, Poh CM, Renia L, MacAry PA, Ng L. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;doi.org/10.1038/s41577-020-0311-8
4.Cascella M, Rajnik M, Cunomo A, Dulebohn SC, Di Napoli R. Feature, Evaluation and Treatment Coronavirus(COVID-19). In; StatPearls[internet]. Treasure Island (FL); StatPearls Publishing.2020.
5.Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19; Report of three cases and a review of literature. J Dermatol Sci 2020; doi10.1016/j.jdermsci.2020.04.011
6. Jia JL, KamcevaM, Rao SA, Linos E. Cutaneous Manifestations of COVID-19; A Preliminary Review. J Am Acad Dermatol 2020;doi.org/10.1016/j.jaad.2020.05.059
7.วาสนภ วชิรมน, พูลเกียรติ สุชนวณิช, บรรณาธิการ.Practical Dermatology. กรุงเทพมหานคร: บริษัท ภาพพิมพ์; 2563.
8.ปรียา กุลละวณิชย์,ประวิตร พิศาลบุตร. บรรณาธิการ. Dermatology 2020.กรุงเทพมหานคร: บริษัท โอลิสติก พับลิชชิ่ง จำกัด; 2555.
9.แนวทางเวชปฏิบัติ การวินิจฉัย ดูแลรักษา และป้องกันการติดเชื้อในโรงพยาบาล กรณีผู้ป่วยติดเชื้อไวรัสโคโรนา 2019 (COVID-19) สำหรับแพทย์และบุคลากรสาธารณสุข โดยคณะทำงานด้านการรักษาพยาบาลและการป้องกันการติดเชื้อในโรงพยาบาล กรมการแพทย์ กระทรวงสาธารณสุข ร่วมกับ คณาจารย์ผู้เชี่ยวชาญ จากคณะแพทยศาสตร์ มหาวิทยาลัยต่างๆ (คณะกรรมการกำกับดูแลรักษาโควิด-19) ฉบับปรับปรุง วันที่ 1 พฤษภาคม พ.ศ.2563
10.Amanda Oakley. Urticaria and Urticaria-like conditions.Derm Net NZ.2011 [cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/urticaria-and-urticaria-like-conditions/
11.Amanda Oakley. Bistering skin conditions.Derm Net NZ.2015 [cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/blistering-skin-conditions/
12.Amanda Oakley.Chilblain.Derm Net NZ.1999[cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/chilblains/
13.Vanessa Ngan, Staff Writer, 2003.. Updated by Dr Sara de Menezes, Basic Physician Trainee, Alfred Health, Melbourne, Australia; Chief Editor, Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, September 2016. LIvedo reticularis. Derm Net NZ.1999[cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/livedo-reticularis/
14.Vanessa Ngan, Staff Writer, 2005. Updated by Hon A/Prof Amanda Oakley, November 2015.Purpura.Derm Net NZ.1999 [cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/purpura/
15.Amanda Oakley.Pityriasis Rosea.Derm Net NZ.2014[cited 2021 Jan 18]. Available from: https://dermnetnz.org/topics/pityriasis-rosea/